NDA 062527 describes NAFCILLIN SODIUM, which is a drug marketed by
Antibiotice,
Apothecon,
Eugia Pharma Speclts,
Fresenius,
Istituto Bio Ita Spa,
Sagent Pharms,
Sandoz,
Steriscience, and
Watson Labs Inc, and is included in fifteen NDAs. It is available from
nine suppliers. Additional details are available on the
NAFCILLIN SODIUM profile page.
The generic ingredient in NAFCILLIN SODIUM is
nafcillin sodium. There are eleven
drug master file entries for this compound. Ten
suppliers are listed for this compound. Additional details are available on the
nafcillin sodium profile page.